Yamamoto, Yoshihiro
Fukuyama, Keita
Kanai, Masashi http://orcid.org/0000-0002-6954-4474
Kondo, Tomohiro
Yoshioka, Masahiro
Kou, Tadayuki
Quy, Pham Nguyen
Kimura-Tsuchiya, Reiko
Yamada, Takahiro
Matsumoto, Shigemi
Kosugi, Shinji
Muto, Manabu
Funding for this research was provided by:
the Japan Agency for Medical Research and Development, AMED (17kk0305006h0001)
Article History
Received: 27 April 2022
Accepted: 6 July 2022
First Online: 23 July 2022
Declarations
:
: Masashi Kanai received lecture fees, honoraria, and other fees from Chugai Pharmaceutical Co., Ltd.; research funding from Molecular Health; stock ownership from Therabiopharma Inc. Manabu Muto received research funding from Chugai Pharmaceutical Co., Ltd.; research funding from Sysmex Corporation. All remaining authors have declared no conflicts of interest.